Pharmacokinetic and Pharmacodynamic Relationship of AMG 811, An Anti-IFN-γ IgG1 Monoclonal Antibody, in Patients with Systemic Lupus Erythematosus
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic and Pharmacodynamic Relationship of AMG 811, An Anti-IFN-γ IgG1 Monoclonal Antibody, in Patients with Systemic Lupus Erythematosus
Authors
Keywords
AMG 811, Lupus, PK/PD modeling, IFN-γ, CXCL10
Journal
PHARMACEUTICAL RESEARCH
Volume 32, Issue 2, Pages 640-653
Publisher
Springer Nature
Online
2014-09-12
DOI
10.1007/s11095-014-1492-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset
- (2014) Paul R Dominguez-Gutierrez et al. ARTHRITIS RESEARCH & THERAPY
- Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration
- (2012) Wolfgang F. Richter et al. AAPS Journal
- IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus
- (2012) Thomas Rose et al. ANNALS OF THE RHEUMATIC DISEASES
- Elevated Serum IL-6, IL-8, MCP-1, CRP, and IFN-? Levels in 10- to 11-Year-Old Boys with Increased BMI
- (2012) L. Utsal et al. Hormone Research in Paediatrics
- Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis
- (2011) Liviawati Sutjandra et al. CLINICAL PHARMACOKINETICS
- Theoretical Considerations of Target-Mediated Drug Disposition Models: Simplifications and Approximations
- (2011) Peiming Ma PHARMACEUTICAL RESEARCH
- Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Nathanael L. Dirks et al. CLINICAL PHARMACOKINETICS
- Role of guanylate binding protein-1 in vascular defects associated with chronic inflammatory diseases
- (2010) Matthias Hammon et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis
- (2010) Nicolas Frey et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Exposure-Response Modeling of Darbepoetin Alfa in Anemic Patients With Chronic Kidney Disease Not Receiving Dialysis
- (2010) Sameer Doshi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Handling Data Below the Limit of Quantification in Mixed Effect Models
- (2009) Martin Bergstrand et al. AAPS Journal
- Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study
- (2009) Jason W. Bauer et al. ARTHRITIS AND RHEUMATISM
- Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus
- (2009) K. O. Kong et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors
- (2009) Peiming Ma et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Selection between Michaelis–Menten and target-mediated drug disposition pharmacokinetic models
- (2009) Xiaoyu Yan et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Approximations of the target-mediated drug disposition model and identifiability of model parameters
- (2008) Leonid Gibiansky et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Likelihood based approaches to handling data below the quantification limit using NONMEM VI
- (2008) Jae Eun Ahn et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started